Photo of Russell Fry
R United States House · District 7 · South Carolina On the 2026 ballot

Rep. Russell Fry

Compare
Total votes
1,879
all sessions
Attendance
99%
10 missed
Higher than 82% of chamber peers
With party
92%
of cast votes
Lower than 88% of chamber peers
Bipartisan score
5%
crosses aisle rarely
Higher than 86% of chamber peers
Sponsored
459
bills & resolutions
Near the chamber average
Committees
7
assignments
459 bills and resolutions

Sponsored bills

Total
459
Primary
30
Co-sponsor
429
This page
459
matching current filters
Co-sponsor HR 9421
In committee · United States House · Co-sponsor
Ban Abortion by Mail Act

Maddy summaryThis bill, titled the Ban Abortion by Mail Act, aims to restrict how abortion medications like mifepristone are prescribed by requiring an in-person visit between the patient and the doctor. It directly affects health care providers who are currently certified by the FDA to dispense these drugs, threatening their certification status if they prescribe them without a physical examination or to patients living in states where the provider lacks a medical license. The legislation mandates that the FDA report annually to Congress on any providers who lose this certification due to violations or unsafe prescribing practices. By enforcing these specific conditions, the bill seeks to ensure that all prescriptions for abortion drugs are administered under strict supervision and within the legal boundaries of the patient's state.

In committee Jun 24, 2026 1 co-sponsor
Co-sponsor HR 4238
Passed · United States House · Co-sponsor
DLARA

Maddy summaryThe Disaster Loan Accountability and Reform Act (DLARA) requires the Small Business Administration (SBA) to improve transparency and accountability for disaster loans. It mandates monthly reports detailing loan funding status, new budget requests with historical cost comparisons, and strict limits on loan obligations when funds fall below 10% of a 10-year average. The bill also requires GAO and SBA Inspector General reviews of funding shortfalls, cost impacts of recent policy changes, and enhanced forecasting for disaster loan budgets. These provisions directly affect the SBA’s operations and its reporting to Congress, aiming to prevent future funding crises through better data and oversight.

Passed Jun 24, 2026 1 co-sponsor
Co-sponsor HR 425
In committee · United States House · Co-sponsor
Repealing Big Brother Overreach Act

Repealing Big Brother Overreach Act This bill repeals the Corporate Transparency Act. The act requires existing companies and newly created companies to report beneficial ownership information to the Department of the Treasury’s Financial Crimes Enforcement Network for purposes of addressing the financing of terrorism and money laundering.

In committee Jun 18, 2026 1 co-sponsor
Co-sponsor HR 9152
In committee · United States House · Co-sponsor
VETRA Act

Maddy summaryThe VETRA Act directs the Department of Veterans Affairs to run a two-year pilot program aimed at upgrading its digital security systems to better protect veterans' benefits and reduce fraud. Under this initiative, the VA will test new multi-layered identity verification methods on up to three high-use platforms, such as those for disability claims, health care enrollment, and educational benefits. The program requires the use of commercially available, independently certified security tools that adjust verification strictness based on the risk level of each transaction. To ensure accountability, the bill mandates regular reports to Congress on performance metrics and requires an independent evaluation by the Government Accountability Office before deciding whether to expand the system nationwide.

In committee Jun 12, 2026 1 co-sponsor
Co-sponsor HR 9298
In committee · United States House · Co-sponsor
Stopping Harmful and Outrageous Torts Act

Maddy summaryThis bill, known as the Stopping Harmful and Outrageous Torts Act, expands legal protections for firearm manufacturers and sellers by strengthening their immunity from civil lawsuits. It requires courts to immediately dismiss any pending cases against these companies that are based on the criminal or unlawful misuse of a gun by a third party, while also clarifying that sellers are not liable for negligence in entrusting products to others. The legislation further restricts who can file such suits by prohibiting foreign governments from bringing these claims and adding a specific exception for victims under the age of 17, though it maintains immunity for cases involving design or manufacturing defects. Additionally, the bill allows companies to move these cases to federal court and grants them the right to appeal dismissal orders immediately, along with the ability to recover legal fees if they win. Finally, it preempts state and local laws that attempt to impose liability on these entities for the same types of misuse-related harms.

In committee Jun 11, 2026 1 co-sponsor
Co-sponsor HR 5437
In committee · United States House · Co-sponsor
Protection of Lawful Commerce in Stone Slab Products Act

Maddy summaryHR 5437, the *Protection of Lawful Commerce in Stone Slab Products Act*, prohibits lawsuits against manufacturers and sellers of stone slab products (like countertops) for injuries caused by silica dust exposure during third-party fabrication (e.g., cutting or grinding by fabricators). It directly affects stone slab manufacturers and sellers by shielding them from civil liability when injuries result from fabricators violating workplace safety laws. The bill’s key provision bans such lawsuits in federal or state courts and requires dismissal of pending cases. It aims to protect this industry, which employs thousands, from claims they cannot control, emphasizing that safety regulations apply to fabricators - not the original sellers.

In committee Jun 3, 2026 1 co-sponsor
Co-sponsor HR 3164
In committee · United States House · Co-sponsor
Ensuring Community Access to Pharmacist Services Act

Maddy summaryThis bill would add pharmacist services to Medicare Part B coverage for beneficiaries, specifically covering pharmacist-led testing and treatment for illnesses like flu, COVID-19, or strep throat during public health emergencies. It defines covered services as those performed under state law, often requiring collaboration with a physician, and sets payment at 80% of the lesser of the actual charge or 85% of physician payment rates. Pharmacists would be prohibited from balance billing for these services, ensuring Medicare beneficiaries pay only their standard copayment. The changes would take effect January 1, 2026.

In committee May 21, 2026 1 co-sponsor
Co-sponsor HR 1329
Failed · United States House · Co-sponsor
Smithsonian American Women’s History Museum Act

Maddy summaryThe Smithsonian American Women’s History Museum Act authorizes the creation of a new Smithsonian museum dedicated to women’s history, to be located within the National Mall Reserve in Washington, D.C. If the site is managed by another federal agency, the bill requires that agency to transfer the land after notifying Congress and relevant committees. The museum must ensure exhibits and programs accurately represent diverse women’s experiences by consulting a broad range of experts and community voices. The Smithsonian will submit biennial reports to Congress detailing how the museum meets these representation standards.

Failed May 21, 2026 1 co-sponsor
Co-sponsor HR 7024
In committee · United States House · Co-sponsor
Hemp Planting Predictability Act

Hemp Planting Predictability Act This bill extends by two years the implementation of changes to the regulation of hemp products, which reimpose certain federal controls over some hemp products. Specifically, Congress enacted the FY2026 agriculture appropriations act (P.L. 119-37) on November 12, 2025. Effective November 12, 2026, the act modifies the statutory definition of hemp products that are considered to be lawful. This bill extends the effective date to November 12, 2028. As background, the 2018 farm bill excluded hemp from the Controlled Substances Act definition of marijuana and defined hemp . As a result, hemp and hemp-derived products at or below the 0.3% delta-9 tetrahydrocannabinol (THC, the psychoactive component of marijuana) concentration threshold were no longer regulated as Schedule I controlled substances and registration with the Drug Enforcement Administration was no longer required to cultivate or handle hemp and hemp-derived products. However, hemp remained subject to Department of Agriculture and Food and Drug Administration regulation. The 2025 changes to the definition of hemp, include changing the limit to a total THC concentration of not more than 0.3% on a dry weight basis rather than only delta-9 THC, explicitly including industrial hemp, excluding seeds from a cannabis plant that exceed a certain THC concentration, and excluding various types of hemp-derived cannabinoid products. Cannabinoids refer to unique chemical compounds that are found in hemp and marijuana (e.g., THC) and are known to exhibit a range of psychological and physiological effects.

In committee May 20, 2026 1 co-sponsor
Co-sponsor HR 8365
Passed · United States House · Co-sponsor
Monitor Accountability Act

Maddy summaryThe Monitor Accountability Act of 2026 directs the Administrator of the Administrative Office of the United States Courts to establish new rules for federal courts appointing monitors to oversee State or local governments. The bill limits monitor fees, caps their service to one monitorship for a maximum of five years, and prevents reappointments under the same court order. It also requires courts to allow public comment before appointing a monitor and mandates annual public accountings of services and fees. Additionally, cases with monitorships lasting six years or more must be transferred to a different judge. These provisions, including the appointment of new monitors and case transfers, apply retroactively to existing monitorships that have been in effect for six years.

Passed May 18, 2026 1 co-sponsor
Showing 21 to 30 of 459 bills
Previous 1 … 2 3 4 … 46 Next